Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Franchimont

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Gut|March 9, 2005
Profile of soluble cytokine receptors in Crohn's diseaseT Gustot, A Lemmers, E Louis, et al.
Gut|April 16, 1998
Anticipation in familial Crohn's diseaseB Grandbastien, M Peeters, D Franchimont, et al.
Journal of Neuroimmunology|June 1, 1997
Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I moleculesY Vanneste, A N Thome, E Vandersmissen, et al.
Clinical and Experimental Immunology|September 16, 1998
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humansE Louis, D Franchimont, A Piron, et al.
Clinical and Experimental Immunology|December 22, 1999
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?E Louis, M Peeters, D Franchimont, et al.
Gut|June 15, 2004
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.
Clinical and Experimental Immunology|May 15, 2009
An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver diseaseA Lemmers, T Gustot, A Durnez, et al.
Acta Gastro-Enterologica Belgica|June 30, 2015
Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)S Vermeire, E Louis, O Dewit, et al.
Revue Medicale De Bruxelles|February 15, 2003
[The medical gastroenterology department]J Devière, M Adler, N Bourgeois, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitisM De Vos, O Dewit, G D'Haens, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Gut|March 9, 2005
Profile of soluble cytokine receptors in Crohn's diseaseT Gustot, A Lemmers, E Louis, et al.
Gut|April 16, 1998
Anticipation in familial Crohn's diseaseB Grandbastien, M Peeters, D Franchimont, et al.
Journal of Neuroimmunology|June 1, 1997
Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I moleculesY Vanneste, A N Thome, E Vandersmissen, et al.
Clinical and Experimental Immunology|September 16, 1998
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humansE Louis, D Franchimont, A Piron, et al.
Clinical and Experimental Immunology|December 22, 1999
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?E Louis, M Peeters, D Franchimont, et al.
Gut|June 15, 2004
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.
Clinical and Experimental Immunology|May 15, 2009
An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver diseaseA Lemmers, T Gustot, A Durnez, et al.
Acta Gastro-Enterologica Belgica|June 30, 2015
Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)S Vermeire, E Louis, O Dewit, et al.
Revue Medicale De Bruxelles|February 15, 2003
[The medical gastroenterology department]J Devière, M Adler, N Bourgeois, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitisM De Vos, O Dewit, G D'Haens, et al.
Pageof 5